3. CASE CONTROL STUDY
ο Retrospective study
οFeatures:
1. Both exposure and outcome have occurred before the start
of the study
2. The study proceeds backwards from effect to cause
3. It uses a control or comparison group to support or refute
an inference
4. Basic Steps
1. Selection of cases and controls
2. Matching
3. Measurement of exposure
4. Analysis and interpretation
5. Selection of cases and controls
β’ SELECTION OF CASE :
The prior definition of what constitutes a case is crucial to
the case control study . It involves 2 specifications
1. Diagnostic criteria
2. Eligibility criteria
β’ SOURCE OF CASES
Cases can be drawn from hospitals or general population.
6. β’ SELECTION OF CONTROLS:
THE CONTROLS MUST BE FREE FROM DISEASE UNDER STUDY
They must be similar to the cases as possible except for the
absence of the disease under study .
SOURCE OF CONTROLS:
Hospitals
Relatives
Neighborhood
General population
One control per case if many cases are available or as many as 2,3
, or even 4 if the study group is small
7. β’ MATCHING :
Defined as the process by which we select controls in such a way
that they are similar to cases with regard to certain pertinent selected
variable which are known to influence the outcome of disease and which
if not adequately for comparability could distort of confound the result .
β’ A confounding factor is defined one which is associated with both
associated disease and is distributed un equally in study and control
groups .
8. β’ Types
1. Group Matching: assigning cases to
subcategories based on their characteristics like agem
occupation, etc. and then establishing appropriate
controls.
2. Pair matching: It is finding a control for
particular case as closely resembling as possible except
for disease under study.
9. β’ MEASUREMNT OF EXPOSURE :
Information of exposure should be obtained precisely in same
manner in both the cases and controls.
It can be recorded by interview, by questionnaires or by
studying past records.
10. β’ ANALYSIS :
t is the final step to find out :
1. Exposure rate among cases and controls to a suspected
factor.
2. Estimation of diseases risk associated with exposure
EXPOSURE RATES
A case control study provides a direct estimation of the exposure to
a suspected factor ion the disease and non-disease groups
11. Exposure rates
Cases :
π
π+π
Controls :
π
π+π
The next step is to ascertain
weather there is a statistical
association between exposure
status and disease occurrence
which is resolved by
calculating p value.
Suspected or
risk factors
Cases
(disease
present)
Controls
(Disdease
Abest)
Present a b
Absent c d
a+c b+d
12. ESTIMATION OF RISK :
It is obtained by an index known a β relative risk β or odds ratio
β’ πππππ‘ππ£π πππ π =
πππππππππ πππππ ππ₯πππ ππ
πππππππππ πππππ πππ ππ₯πππ ππ
β’ Odds ratio is the measure of the strength of association
between the risk factor and outcome .it based on 3
assumptions :
1. disease being investigated must be relatively rare .
2. case must be representative of those with the disease
3. controls mist be representative of those withput the
disease.
odds ratio = ad / bc.
13. ADVANTAGES
β’ Relatively easy to carry out
β’ Rapid and inexpensive compared to
cohort study
β’ Requires comparatively few
subjects
β’ No risk to the subject
β’ Allows the study of several different
etiological factors like effect of
smoking, physical activity, diet.
DISADVANTAGES
β’ Problems of bias
β’ Selection of an appropriate control
group may be difficult
β’ Incidence cannot be measured, only
relative risk can be estimated
β’ Not suited for evaluation of therapy
or prophylaxis of disease
14. COHORT STUDY:
β’ Definition: it is a type of study usually undertaken to obtain
additional evidence to refute or support the existence of an
association between suspected cause and disease.
β’ Characteristics
1. Cohorts are identified prior the appearance of the disease
under investigation .
2. The study groups are observed over a period of time to
determine the frequency of the disease among them .
3. The study proceeds forward from cost to effect
15. β’ COHORT SELECTION :
Cohort is a group of peple who share a common characteristic or
experience within a definite time period.
β’ For selecting a cohort the following facts should be considered
1. Cohorts must be free form the disease under study.
2. Both the study and control cohorts should be equally
susceptible to the disease under study.
3. Both the cohort must be comparable in respect to all
possible variable which may Influence the frequency of
the disease.
17. TYPES OF COHORT STUDY
COHORT
STUDIES
PROSPECTIVE RETROSPECTIVE
COMBINATION
OF BOTH.
18. STEPS OF COHORT STUDY :
β’ Selection of study subjects
β’ Obtaining data on exposure
β’ Selection of comparison groups
β’ Follow up
β’ Analysis
19. β’ SELECTION OF STUDY SUBJECT :
Subjects of a cohort study are usually assembled from general
population or special groups .
β’ OBTAINING DATA ON DATA EXPOSURE :
Information about exposure is obtained directly from any one or
all of the following sources :
Cohort members , review of records , medical examinations
or special tests and environmental surveys
20. β’ SELECTION OF COMPARISON GROUPS :
There are many ways of assembling a group .
1. Internal comparison : when a single cohort enters the
study, on the basis of information obtained, be classified
into several comparison groups according to the degrees of
levels of exposure to risk before the development of disease in
question.
2.External comparison : when the degree of comparison is
not available , it is necessary to put up an external , to
evaluate the experience of the exposed group .
3.Comparison with general population rates .
21. 4. FOLLOW UP COMPRISES OF:
1.Period medical examination of each member if the cohort
2.Reviewing physician and hospital records
3.Routine surveillance of death records
4.Mailed questionnaires , telephone calls and periodic home
visits.
β’ Limitation :
A certain percentage of losses to follow up are inevitable due to
death , change of residence , migration , or withdrawal of
occupation .
These losses may bias the result .
23. β’ INCIDENCE RATES:
Among cases:
π
π+π
Among controls :
π
π+π
β’ ESTIMATION OF RISK
-Relative risk
-Attributable risk
-Absolute risk
24. β’ Relative Risk:
It is the direct measure of strength of the association
between suspected cause and effect.
β’ Relative risk:
πππππππππ ππ πππ πππ π πππππ ππ₯πππ ππ
πππππππππ ππ πππ πππ π πππππ πππβππ₯πππ ππ
Interpretation: I exp= I nonexp = no correlation
I exp> I nonexp = Positive association
I exp < I nonexp = negative correlation
25. β’ Attributable Risk: It is the difference in incidence rates of disease
between an exposed group and non exposed group
β’ =
πππππππππ ππ πππ πππ π πππ‘π πππππ ππ₯πππ ππ+πππππππππ ππ πππ πππ π πππ‘π πππππ πππ ππ₯πππ ππ
π‘ππ‘ππ π π‘π’ππ¦ ππππ’πππ‘πππ
x100
β’ It signifies potential for prevention.
26. β’ Absolute risk:
Risk of developing the disease, irrespective of exposure
to risk factor and is expressed in percentage.
β’ =
πππππππππ πππππ ππ₯πππ ππ+πππππππππ πππππ πππ ππ₯πππ ππ
total study population
x100
27. ADVANTAGES
β’ Incidence can be calculated
β’ Several possible outcomes
related to exposure can be
studied simulateously
β’ Provide a direct estimation of
relative risk
β’ Dose-response ratios can also
be calculated
β’ DISADVANTAGES
β’ Involve a large number of
people
β’ General unsuitable for
investigating uncommon
disease or diseases with low
incidence in the population
β’ Long time to complete study
β’ Loss of substantial proportion
of cohort due to migration,
loss of interest.
β’ Expensive
Diagnostic : before the study id started the diagnostic criteria of the disease and the stage of disease if any to be included in study should be clearly specified
Eligibity : a customary criterion is that only newly diagnosed cases within a specified period of time are eligible than old cases or cases in advanced stage of disease
Particular tests of significance depends upon the variables under investigation
In case of discrete variables, results are presented as rates or proportions of those present or absent in the study in the control group and usual test of significance is standard error of difference betwenn two proportions or chi square test
P <0.05 is statistically significant
Indications: when thereis good evidence of an association between exposure and disease, as derived from clinical observation and supported by descriptive and case control studied
When exposure is rare but incidence is high among exposed
When attrition of study population can be minimized
When ample funds are available
It consists of two cohorts
Study cohort consisting of people exposed to a particular agent thought to be ralted to disease occurrence
Control cohort consisting of people not exposed to that particular agent
Prospective: one in which the outcome has not yet occurred at the time the investigation begins . Aka current cohort
Retrospective: historical cohort study in which outcomes have all occurred before the start of the investigation
Combination:the cohort is identifies from past records and is assessed of date for the outcome and is followed up prospectively into the future for further assessemtn of outcome
Special grps: select goups : professional grps, insured persons, obstretic populatons, college alumni, govt employees, volunteers
Exposure grps: if exposure is rare, a cohort person known to have experienced the exposure to physical chemical and other disease agent is selected
If none is available the mortality experience of the exposed grp is compared with the mortality experience of the general population in the same geographical area as the exposed group
Limitations: non availability of population rates for the outcome required
Difficulties of selecting the study and comparison groups which are representative of the exposed and non exposed segments of the general population
Population attributable risk
It is the diffence between the incidence of the disease occurring in the total population of both the groups irrespective of risk factor and incidence among the control groups